SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-22-000229
Filing Date
2022-08-11
Accepted
2022-08-11 07:13:25
Documents
11
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF AUGUST, 2022 imv6kq2fs.htm 6-K 5908
2 INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDED JUNE 30, 2022 exhibit99-1.htm EX-99.1 265974
3 MANAGEMENT DISCUSSION AND ANALYSIS FOR THE PERIOD ENDED JUNE 30, 2022 exhibit99-2.htm EX-99.2 333576
4 CEO CERTIFICATION exhibit99-3.htm EX-99.3 8430
5 CFO CERTIFICATION exhibit99-4.htm EX-99.4 8497
6 ex99-1_001.jpg GRAPHIC 8799
7 ex99-2_001.jpg GRAPHIC 4071
8 ex99-2_002.jpg GRAPHIC 219096
9 ex99-2_003.jpg GRAPHIC 164557
10 ex99-2_004.jpg GRAPHIC 132319
11 ex99-2_005.jpg GRAPHIC 111005
  Complete submission text file 0001176256-22-000229.txt   1505393
Mailing Address 130 EILEEN STUBBS AVE. SUITE 19 DARTMOUTH A5 B3B 2C4
Business Address 130 EILEEN STUBBS AVE. SUITE 19 DARTMOUTH A5 B3B 2C4 9024921819
IMV Inc. (Filer) CIK: 0001734768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38480 | Film No.: 221153660
SIC: 2834 Pharmaceutical Preparations